Adverse Drug Reactions (ADR’S) monitoring at tertiary care Hospital
The observational and brief cross section study was conducted in the ADR monitoring centre, department of pharmacology, SVS MEDICAL HOSPITAL. The adverse drug reactions (ADR) reported by physician of dermatology department of SVSMH were collected and then causality, severity and preventability assessment was done. The results were presented as number and percentage. Total of 544 patients were observed with 15 suspected ADRs. The incidence of dermatological ADR was 3.78%. Maximum incidence of dermatological ADRs were observed with anti-inflammatory agents and immunosuppressive (33.30%) followed by antibiotic drugs (13.3%).Dermatological adverse drug reactions were a common occurrence and awareness about them was found to be essential for early detection and prevention. The healthcare system can promote the spontaneous reporting of dermatological ADR top Pharmacovigilance centre's for ensuring safe drug use and patient care. . Most of the reported ADRs were possible, definitely preventable and mild in nature. Our study suggests that there is a need of intensive monitoring for ADRs in tertiary care hospital for early detection and to ensure the patient safety.
Keywords: adverse drug reaction, casualty, severity, probability.
2. Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication‐related adverse events in nursing homes. Am. J. Geriatr. Pharmacother. 2006; 4:264–272.
3. Adverse Drug Reactions National Medicines Information Centre 2002; 8:1‐4
4. Levy M, Livshits TA, Sadan B, Shalit M, Brune K, Computerized surveillance of adverse drug reactions in hospital: Implementation. Eur. J. Clin. Pharmacol. 1999; 54:887‐92.
5. The National Pharmacovigilance Program was established in 2004 in India by CDSCO.
6. Lazarou J, Pomeranz BH, Corey PN. Incidance of Adverse Drug reactions in hospitalized patients: A meta analysis of prospective studies. JaMA. 1998; 279:1200-5.
7. WHO collaborating centre for international drug monitoring, the uppasala monitoring centre. Adverse reaction and adverse drug reaction monitoring training course 31st May to 11th June 1999.
8. American Psychiatric Associaton, 1000 Wilson Boulevard, Suite 1825 Arlington, VA 22209-3901. www.psych.org
9. Naranjo CA., Busto U., Sellers EM., Sandor P., Ruiz I., Roberts EA., et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol ther.1981; 30:239-45.
10. Hartwig SC., Siegel J., Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J hosp pharm. 1992; 49:2229-31. Mahapatra S., Keshri Pd U. Adverse cutaneous drug reactions in tertiary care center patients: A prospective analysis. J App Pharm Sci. 2012; 2:96-8.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).